Citadel Advisors’s ModivCare MODV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-211,100
Closed -$659K 13607
2025
Q2
$659K Buy
+211,100
New +$389K ﹤0.01% 7987
2025
Q1
Sell
-11,800
Closed -$140K 15183
2024
Q4
$140K Buy
11,800
+1,900
+19% +$30.1K ﹤0.01% 10995
2024
Q3
$141K Buy
9,900
+5,000
+102% +$115K ﹤0.01% 10643
2024
Q2
$129K Sell
4,900
-23,400
-83% -$592K ﹤0.01% 10557
2024
Q1
$664K Buy
28,300
+20,700
+272% +$758K ﹤0.01% 7777
2023
Q4
$334K Sell
7,600
-2,900
-28% -$114K ﹤0.01% 8953
2023
Q3
$331K Buy
10,500
+6,400
+156% +$250K ﹤0.01% 8971
2023
Q2
$185K Buy
4,100
+1,000
+32% +$59.4K ﹤0.01% 10009
2023
Q1
$261K Hold
3,100
﹤0.01% 9678
2022
Q4
$278K Sell
3,100
-600
-16% -$53.5K ﹤0.01% 9484
2022
Q3
$369K Buy
+3,700
New +$383K ﹤0.01% 9126
2022
Q2
Sell
-6,800
Closed -$785K 13647
2022
Q1
$785K Sell
6,800
-900
-12% -$104K ﹤0.01% 8261
2021
Q4
$1.14M Sell
7,700
-6,900
-47% -$1.07M ﹤0.01% 7622
2021
Q3
$2.65M Buy
14,600
+2,100
+17% +$374K ﹤0.01% 5651
2021
Q2
$2.13M Buy
12,500
+4,400
+54% +$659K ﹤0.01% 6453
2021
Q1
$1.2M Hold
8,100
﹤0.01% 7653
2020
Q4
$1.12M Buy
8,100
+4,200
+108% +$521K ﹤0.01% 6560
2020
Q3
$362K Buy
+3,900
New +$338K ﹤0.01% 7819
2019
Q1
Sell
-5,500
Closed -$330K 9643
2018
Q4
$330K Sell
5,500
-1,900
-26% -$126K ﹤0.01% 7090
2018
Q3
$498K Sell
7,400
-700
-9% -$48.6K ﹤0.01% 6707
2018
Q2
$636K Sell
8,100
-300
-4% -$22.5K ﹤0.01% 5984
2018
Q1
$581K Buy
+8,400
New +$548K ﹤0.01% 5645
2016
Q1
Sell
-1,000
Closed -$47K 7522
2015
Q4
$47K Buy
+1,000
New +$48K ﹤0.01% 7367

Other funds holding MODV

Citadel Advisors's MODV Position: Q3 2024 in Review

Citadel Advisors sold out of ModivCare (MODV) in Q3 2024, closing a stake of 46,369 shares — an estimated $1.06M sold.

Citadel Advisors first reported a position in MODV in Q2 2013 and held it in 34 quarters. The position peaked at $9.55M in Q1 2023. 108 funds tracked by Wall St. Rank hold MODV as of Q3 2024.

  • Citadel Advisors reported no remaining ModivCare position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 46,369 ModivCare shares in Q3 2024, an estimated $1.06M.
  • Citadel Advisors first reported a position in ModivCare in Q2 2013 and held it in 34 quarters.
  • Citadel Advisors's ModivCare position peaked at $9.55M in Q1 2023.
  • 108 funds tracked by Wall St. Rank held ModivCare as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.